Finance

Lists
Why is EOLS up 8.96%?
Dive Deeper
EOLS:NASDAQ
Evolus Inc
$7.42
+8.96%
(+0.61) 1D
$7.42
0.00% (0.00)
After hours
Closed: Nov 11, 4:00:00 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for EOLS...
Open
$6.87
High
$7.44
Low
$6.85
Mkt. cap
491.12M
Avg. vol.
1.02M
Volume
1.29M
52-wk high
$9.31
52-wk low
$3.86
EPS
-$0.53
Beta
1.38
Shares outstanding
66.19M
No. of employees
365
Open
$6.87
High
$7.44
Low
$6.85
Mkt. cap
491.12M
Avg. vol.
1.02M
Volume
1.29M
52-wk high
$9.31
52-wk low
$3.86
EPS
-$0.53
Beta
1.38
Shares outstanding
66.19M
No. of employees
365
News stories
From web sources and news partners
About Evolus Inc
CEODavid Moatazedi
Employees365
Founded2012
HeadquartersNewport Beach, California, United States
SectorHealth Care
IndustryPharmaceutical industry
Websiteevolus.com
Analyst ratings
Based on 4 analysts giving stock ratings to EOLS in the past 3 months
Strong buy
Buy
4
Hold
0
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for EOLS in the last 3 months.
Highest
Current $7.42
$20.00 (+169.54%)
Average
$16.25 (+119.00%)
Lowest
$13.00 (+75.20%)
Analyst
Recommendation
Action
Price target
Projected
Date
Marc Goodman
Leerink Partners
Buy
Maintained
$20.00
+169.5%
11/05/2026
Annabel Samimy
Stifel Nicolaus
Buy
Reiterated
$17.00
+129.1%
11/05/2026
Sam Eiber
BTIG
Buy
Maintained
$15.00
+102.2%
11/05/2026
Douglas Tsao
H.C. Wainwright
Buy
Reiterated
$13.00
+75.2%
11/05/2026
Uy Ear
Mizuho Securities
Buy
Maintained
$15.00
+102.2%
09/10/2026
Serge Belanger
Needham
Hold
Maintained
-
-
08/06/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
90.30M
73.14M
84.08M
77.95M
Cost of goods sold
31.01M
24.24M
27.96M
27.27M
Cost of revenue
31.01M
24.24M
27.96M
27.27M
Research and development expenses
3.48M
2.24M
1.89M
1.97M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
54.66M
51.98M
57.05M
52.92M
Operating expense
59.58M
55.76M
60.47M
56.47M
Total operating expenses
90.59M
80.00M
88.43M
83.73M
Operating income
-291.00K
-6.86M
-4.34M
-5.78M
Other non operating income
10.00K
120.00K
213.00K
148.00K
EBT including unusual items
515.00K
-10.42M
-8.21M
-12.23M
EBT excluding unusual items
-4.00M
-10.43M
-8.01M
-9.58M
Income tax expense
385.00K
256.00K
-154.00K
285.00K
Effective tax rate
74.76%
-2.46%
1.88%
-2.33%
Other operating expenses
-
-
-
-
Net income
130.00K
-10.67M
-8.05M
-12.52M
Net profit margin
0.14%
-14.59%
-9.58%
-16.06%
Earnings per share
0.01
-0.05
-0.02
-0.04
Interest and investment income
263.00K
285.00K
296.00K
296.00K
Interest expense
-3.98M
-3.98M
-4.17M
-4.25M
Net interest expenses
-3.72M
-3.69M
-3.88M
-3.95M
Depreciation and amortization charges
1.45M
1.54M
1.53M
1.58M
EBITDA
1.96M
-4.52M
-2.01M
-3.40M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google apps